Her2Net: A Deep Framework for Semantic Segmentation and Classification of Cell Membranes and Nuclei in Breast Cancer Evaluation

• Published in: IEEE transactions on image processing Vol. 27; no. 5; pp. 2189 - 2200
• Main Authors: Saha, Monjoy, Chakraborty, Chandan
• Format: Journal Article
• Language: English
• Published: United States IEEE 01.05.2018
• Subjects: Biomembranes; Breast - chemistry; Breast - cytology; Breast - diagnostic imaging; Breast cancer; Breast Neoplasms - chemistry; Breast Neoplasms - diagnostic imaging; cell membrane; Cell Membrane - chemistry; Cell Membrane - classification; Cell Nucleus - chemistry; Cell Nucleus - classification; Deep Learning; Female; Fish; HER2; Histocytochemistry; Humans; Image color analysis; Image Interpretation, Computer-Assisted - methods; Image segmentation; LSTM; Machine learning; nuclei; Receptor, ErbB-2; Software
• ISSN: 1057-7149; 1941-0042
• DOI: 10.1109/TIP.2018.2795742

We present an efficient deep learning framework for identifying, segmenting, and classifying cell membranes and nuclei from human epidermal growth factor receptor-2 (HER2)-stained breast cancer images with minimal user intervention. This is a long-standing issue for pathologists because the manual quantification of HER2 is error-prone, costly, and time-consuming. Hence, we propose a deep learning-based HER2 deep neural network (Her2Net) to solve this issue. The convolutional and deconvolutional parts of the proposed Her2Net framework consisted mainly of multiple convolution layers, max-pooling layers, spatial pyramid pooling layers, deconvolution layers, up-sampling layers, and trapezoidal long short-term memory (TLSTM). A fully connected layer and a softmax layer were also used for classification and error estimation. Finally, HER2 scores were calculated based on the classification results. The main contribution of our proposed Her2Net framework includes the implementation of TLSTM and a deep learning framework for cell membrane and nucleus detection, segmentation, and classification and HER2 scoring. Our proposed Her2Net achieved 96.64% precision, 96.79% recall, 96.71% F-score, 93.08% negative predictive value, 98.33% accuracy, and a 6.84% false-positive rate. Our results demonstrate the high accuracy and wide applicability of the proposed Her2Net in the context of HER2 scoring for breast cancer evaluation.